ERBB2 and breast carcinoma: The chemotherapy approaches vary based on assorted parameters that are critical and affect the prognosis and progression of the disease (e.g., the amount of estrogen and progesterone receptors, human epidermal growth factor type 2 receptors (HER2/neu) in patients with breast cancer).